PD-1 in human NK cells: evidence of cytoplasmic mRNA and protein expression

Oncoimmunology. 2018 Dec 25;8(3):1557030. doi: 10.1080/2162402X.2018.1557030. eCollection 2019.

Abstract

Under physiological conditions, PD-1/PD-L1 interactions regulate unwanted over-reactions of immune cells and contribute to maintain peripheral tolerance. However, in tumor microenvironment, this interaction may greatly compromise the immune-mediated anti-tumor activity. PD-1+ NK cells have been detected in high percentage in peripheral blood and ascitic fluid of ovarian carcinoma patients. To acquire information on PD-1 expression and physiology in human NK cells, we analyzed whether PD-1 mRNA and protein are present in resting, surface PD-1-, NK cells from healthy donors. Both different splicing isoforms of PD-1 mRNA and a cytoplasmic pool of PD-1 protein were detected. Similar results were obtained also from both in vitro-activated and tumor-associated NK cells. PD-1 mRNA and protein were higher in CD56dim than in CD56bright NK cells. Confocal microscopy analyses revealed that PD-1 protein is present in virtually all NK cells analyzed. The present findings are compatible with a rapid surface expression of PD-1 in NK cells in response to appropriate, still undefined, stimuli.

Keywords: CD56dim CD56bright; Natural killer cells; PD-1; PD-1 cytoplasmic pool; checkpoint inhibitors; mRNA isoforms.

Publication types

  • Research Support, Non-U.S. Gov't

Grants and funding

The present study has been supported by the following grants: Associazione Italiana per la Ricerca sul Cancro (AIRC) [IG 2014 Id. 15283] (LM), [IG 2017 Id. 19920] (LM), [IG 2017 Id. 20312] (AM), Special Project 5 × 1000 no.21147 (LM, AM), Ricerca Corrente Bambino Gesù Children's Hospital [201807P004255] (LM), Progetto Roche per la Ricerca 2017 (SP, EM), and Ministero della Salute [GR-2013-02356568] (PV).